Ann & Robert H. Lurie Children’s Hospital of Chicago launched a newborn screening awareness campaign, with signage on public transit and billboards across Chicago urging parents to contact their child ...

A new study from the University of Chicago Medicine reveals that people with alcohol use disorder (AUD) and depression experience high levels of stimulation and pleasure when intoxicated, similar to ...

INABIO is rapidly becoming one of the foremost entities for biodiversity research and education in South America, expanding recently with a new building to house its public exhibits and updated ...

"For the National Biodiversity Institute of Ecuador, it has been an absolute privilege to have been a beneficiary of the Dinardo Jr. Trust, thanks to the close collaboration of our colleagues at The ...

In a study to be presented today at the Society for Maternal-Fetal Medicine’s (SMFM) annual meeting, The Pregnancy Meeting™, researchers will unveil findings that suggest that nationwide more pregnant ...

The development of innovative robots and AI solutions will make it possible to automatically record sewer pipe conditions, ...

To test whether humans still use auricular muscles — which once helped move our primate ancestors’ ears to funnel sound — scientists attached electrodes to the sides of people’s heads, and asked them ...

Mount Sinai doctors will present new research on use of artificial intelligence systems, and more, at 2025 SMFM Annual Pregnancy Meeting ...

New research from the University of Minnesota and Boston University School of Public Health (BUSPH) shows that death rates for early adults, or adults aged 25-44, rose sharply during the COVID-19 ...

Researchers compared the environmental impacts of lithium-ion battery recycling to mining for new materials and found that ...

While many studies have reported a link between a mother’s health condition during pregnancy and her child’s risk of autism, a new study shows that nearly all of these “associations” can otherwise be ...

In this cohort study, most patients with overweight or obesity discontinued glucagon-like peptide-1 receptor agonist (GLP-1 RA) therapy within 1 year, but those without type 2 diabetes had higher ...